Seelos Therapeutics (NASDAQ: SEEL)
Some price data may be temporarily unavailable.
SEEL.Q
Key Data Points
Current Price
$0.00
Daily Change
(-) $0.00
Day's Range
$0.00 - $0.00
Previous Close
$0.00
Open
$0.00
Beta
0
Volume
-
Average Volume
-
Sector
Market Cap
-
Market Cap / Employee
-
52wk Range
$0.00 - $0.00
Revenue
$2M
Gross Margin
%
Dividend Yield
N/A
EPS
-
CAPs Rating
-
Industry
Pharmaceuticals
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Seelos Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Seelos Therapeutics Company Info
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
News & Analysis
Featured Article
Why Seelos Therapeutics Stock Is Jumping Today
The company has been included in the first U.S. psychedelics-focused ETF.
Keith Speights | Jun 1, 2021
Featured Article
Why Seelos Therapeutics Dived by 24% Today
Good news from a clinical study was overshadowed by a recommendation downgrade from an analyst.
Eric Volkman | May 17, 2021
Financial Health
General
Q2 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q2 2024 | YoY Change |
---|
Liabilities
Q2 2024 | YoY Change |
---|
Ratios
Q2 2024 | YoY Change |
---|
Cash Flow
Q2 2024 | YoY Change |
---|
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.